Millennium Management’s CalciMedica CALC Stock Holding History

Millennium Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,855	Closed	-$97.9K	–	5761
2025 Q4	$97.9K	Sell	14,855 -19,533	-57%	-$76.2K	﹤0.01%	5636
2025 Q3	$104K	Sell	34,388 -18,482	-35%	-$53.2K	﹤0.01%	5698
2025 Q2	$80.9K	Sell	52,870 -6,518	-11%	-$11.2K	﹤0.01%	5538
2025 Q1	$113K	Sell	59,388 -12,669	-18%	-$31.6K	﹤0.01%	5416
2024 Q4	$255K	Buy	72,057 +16,824	+30%	+$59K	﹤0.01%	5160
2024 Q3	$245K	Sell	55,233 -6,354	-10%	-$27.9K	﹤0.01%	5319
2024 Q2	$244K	Sell	61,587 -4,547	-7%	-$22.9K	﹤0.01%	5032
2024 Q1	$275K	Buy	+66,134	New	+$302K	﹤0.01%	5186
2021 Q3	–	Sell	-1,655	Closed	-$126K	–	6803
2021 Q2	$126K	Buy	+1,655	New	+$109K	﹤0.01%	6172
2020 Q4	–	Sell	-6,451	Closed	-$1.15K	–	5213
2020 Q3	$1.15K	Buy	+6,451	New	+$1.35M	﹤0.01%	3040

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's CALC Position: Q1 2026 in Review

Millennium Management sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 14,855 shares — an estimated $97.9K sold.

Millennium Management first reported a position in CALC in Q3 2020 and held it in 10 quarters. The position peaked at $275K in Q1 2024. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

Millennium Management reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 14,855 CalciMedica shares in Q1 2026, an estimated $97.9K.
Millennium Management first reported a position in CalciMedica in Q3 2020 and held it in 10 quarters.
Millennium Management's CalciMedica position peaked at $275K in Q1 2024.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.